SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
2020 · Nature · 1,819 citations
https://doi.org/10.1038/s41586-020-2852-1
C
Christopher O. Barnes
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
14.4K
Citations
41
h-index
63
i10-index
Christopher O. Barnes is an academic researcher from Chan Zuckerberg Initiative (United States). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Monoclonal and Polyclonal Antibodies Research & HIV Research and Treatment. The author has an h-index of 41, co-authored 98 publications.
ORCID: 0000-0003-2754-5951Papers by this author
worksNaturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
2021 · Nature · 789 citations
https://doi.org/10.1038/s41586-021-03696-9
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
2021 · Nature Communications · 463 citations
https://doi.org/10.1038/s41467-021-24435-8
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
2021 · Immunity · 307 citations
https://doi.org/10.1016/j.immuni.2021.07.008
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
2018 · Nature Communications · 115 citations
https://doi.org/10.1038/s41467-018-03632-y
Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
2018 · Cell Host & Microbe · 109 citations
https://doi.org/10.1016/j.chom.2018.09.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat